Acquisition - Hologic entered into an agreement to be acquired by Blackstone and TPG for $76 per share in cash plus a contingent value right of up to $3 per share, potentially reaching $79 per share[13] - The acquisition is expected to close in the first half of calendar year 2026[13] Financial Performance - Hologic's Q4'25 GAAP revenue was $1,049.5 million, a 6.2% increase compared to Q4'24[68] - Q4'25 Non-GAAP revenue was also $1,049.5 million, with organic revenue at $1,027.7 million and organic revenue excluding COVID at $998.6 million[69] - Hologic's GAAP diluted EPS for Q4'25 was $0.83, a 9.2% increase[68] - Non-GAAP diluted EPS for Q4'25 was $1.13, an 11.9% increase[69] - The company's net debt to adjusted EBITDA leverage ratio is 0.4x[59, 111] Segment Performance - Diagnostics revenue in Q4'25 was $454.1 million[70] - Breast Health revenue in Q4'25 was $393.7 million[70] - GYN Surgical revenue in Q4'25 was $172.5 million[70] - Skeletal Health revenue in Q4'25 was $29.2 million, a 128.1% increase[70]

Financial Performance - Q3'25 GAAP revenue reached $10238 million, a 12% increase compared to Q3'24 [67] - Q3'25 Non-GAAP revenue also reached $10238 million, with a 12% increase or 04% on a constant currency basis [68] - The company's full-year 2025 revenue guidance is between $4081 million and $4091 million, representing a 13% to 15% increase [71] - Non-GAAP diluted EPS for the full year 2025 is projected to be between $423 and $426, a 37% to 44% increase [71] Segment Performance - Diagnostics revenue in Q3'25 was $4489 million, a 09% increase [69] - Breast Health revenue in Q3'25 was $3652 million, a decrease of 58% [69] - GYN Surgical revenue in Q3'25 was $1784 million, a 63% increase [69] - Skeletal Health revenue in Q3'25 was $313 million, a substantial increase of 621% [69] Strategic Positioning - The company's net debt leverage ratio is 06x, with $19 billion in cash and investments as of Q3'25 [59] - The company has deployed over $57 billion since FY20, including $36 billion on share repurchases and $21 billion on M&A [60] - The company aims to continue double-digit non-GAAP EPS growth, driven by mid-single-digit revenue growth, modest operating margin expansion, regular acquisitions, and meaningful buybacks [57]